MicroRNA-574-3p, identified by microRNA library-based functional screening, modulates tamoxifen response in breast cancer

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Ujihira, T ^a,b   Ikeda, K ^a   Suzuki, T ^c   Yamaga, R ^a,d   Sato, W ^a   Horie Inoue, K ^a   Shigekawa, T ^a   Osaki, A ^a   Saeki, T ^a   Okamoto, K ^e   Takeda, S ^b   Inoue, S ^a,d  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; AFIMOXIFENE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ANTISENSE OLIGONUCLEOTIDE; CLATHRIN; MESSENGER RNA; MICRORNA; MIRN574 MICRORNA, HUMAN; SMALL INTERFERING RNA; TAMOXIFEN;

3' UNTRANSLATED REGION; ALGORITHM; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; BINDING SITE; BREAST TUMOR; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECTS; FEMALE; GENE LIBRARY; GENETICS; HUMAN; MCF 7 CELL LINE; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; RNA INTERFERENCE; SEQUENCE ALIGNMENT; UPREGULATION;

3' UNTRANSLATED REGIONS; ALGORITHMS; ANTINEOPLASTIC AGENTS, HORMONAL; BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CELL PROLIFERATION; CLATHRIN; DOWN-REGULATION; FEMALE; GENE LIBRARY; HUMANS; MCF-7 CELLS; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SEQUENCE ALIGNMENT; TAMOXIFEN; UP-REGULATION;

EID: 84934446389     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07641     Document Type: Article

References (44)

1. Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095-2128 (2012).
2. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 351, 1451-1467 (1998).
3. Jordan, V. C., Murphy, C. S. Endocrine pharmacology of antiestrogens as antitumor agents. Endocr Rev 11, 578-610 (1990).
4. Cole, M. P., Jones, C. T., Todd, I. D. A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI 46474. Br J Cancer 25, 270-275 (1971).
5. Cuzick, J. et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 12, 21-29 (2011).
6. Ring, A., Dowsett, M. Mechanisms of tamoxifen resistance. Endocr Relat Cancer 11, 643-658 (2004).
7. Iorio, M. V., Croce, C. M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4, 143-159 (2012).
8. Croce, C. M. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10, 704-714 (2009).
9. Dykxhoorn, D.M.MicroRNAs and metastasis: little RNAs go a long way. Cancer Res 70, 6401-6406 (2010).
10. Filipowicz, W., Bhattacharyya, S. N., Sonenberg, N. Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight Nat Rev Genet 9, 102-114 (2008).
11. Ward, A. et al. Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene 32, 1173-1182 (2013).
12. Bergamaschi, A., Katzenellenbogen, B. S. Tamoxifen downregulation of miR-451 increases 14-3-3f and promotes breast cancer cell survival and endocrine resistance. Oncogene 31, 39-47 (2012).
13. Zhang, B., Pan, X., Cobb, G. P., Anderson, T. A. microRNAs as oncogenes and tumor suppressors. Dev Biol 302, 1-12 (2007).
14. Mayr, C., Hemann, M. T., Bartel, D. P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315, 1576-1579 (2007).
15. Kim, S. J. et al. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7. Breast Cancer Res 14, R14 (2012).
16. Yun, J. et al. Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J 30, 4500-4514 (2011).
17. Qian, P. et al. Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. Cancer Res 71, 6463-6474 (2011).
18. Mattie, M. D. et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5, 24 (2006).
19. Scott, G. K. et al. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem 282, 1479-1486 (2007).
20. Chiyomaru, T. et al. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. PloS One 8, e58929 (2013).
21. Jan, C. H., Friedman, R. C., Ruby, J. G. Bartel DP. Formation, regulation and evolution of Caenorhabditis elegans 39UTRs. Nature 469, 97-101 (2011).
22. Paraskevopoulou, M. D. et al.DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res 41 (Web Server issue) W169-W173 (2013).
23. Wang, X., El Naqa, I. M. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 24, 325-332 (2008).
24. Betel, D., Wilson, M., Gabow, A., Marks, D. S., Sander, C. Targets and expression. Nucleic Acids Res 36 (Database Issue) D149-D153 (2008).
25. Seimiya, M. et al. Identification of novel immunohistochemical tumormarkers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase. Hepatology 48, 519-530 (2008).
26. Di Tommaso, L. et al. Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma. Hepatology 53, 1549-1557 (2011).
27. Rhodes, D. R. et al.Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9, 166-180 (2007).
28. Györffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 123, 725-731 (2010)
29. Honeywell, D. R., Cabrita, M. A., Zhao, H., Dimitroulakos, J., Addison, C. L. miR-105 inhibits prostate tumour growth by suppressing CDK6 levels. PLoS One 8, e70515 (2013).
30. Yan, H.,Wang, S., Yu, H., Zhu, J., Chen, C. Molecular pathways and functional analysis of miRNA expression associated with paclitaxel-induced apoptosis in hepatocellular carcinoma cells. Pharmacology 92, 167-174 (2013).
31. Jérôme, T., Laurie, P., Louis, B., Pierre, C. Enjoy the silence: the story of let-7 microRNA and cancer. Curr Genomics 8, 229-233 (2007).
32. Takamizawa, J. et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64, 3753-3756 (2004).
33. Akao, Y., Nakagawa, Y., Naoe, T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29, 903-906 (2006).
34. Shibahara, Y. et al. Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1. J Pathol 227, 357-366 (2012).
35. Tatarano, S. et al. Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines. Int J Oncol 40, 951-959 (2012).
36. Su, Y. et al. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p. Int Immunopharmacol 13, 468-475 (2012).
37. Kirchhausen, T. Clathrin. Annu Rev Biochem 69, 699-727 (2000).
38. Mellman, I. Endocytosis and molecular sorting. Annu Rev Cell Dev Biol 12, 575-625 (1996).
39. Schmid, S. L. Clathrin-mediated endocytosis: a universe of new questions. Mol Biol Cell 21, 3818-3819 (2010).
40. Royle, S. J., Bright, N. A., Lagnado, L. Clathrin is required for the function of the mitotic spindle. Nature 434, 1152-1157 (2005).
41. Tung, K. H. et al. CHC promotes tumor growth and angiogenesis through regulation of HIF-1a and VEGF signaling. Cancer Lett 331, 58-67 (2013).
42. Joffre, C. et al. A direct role for Met endocytosis in tumorigenesis. Nat Cell Biol 13, 827-837 (2011).
43. Okamoto, K. et al. miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver. EMBO J 31, 1752-1763 (2012).
44. Ma, X. J., Dahiya, S., Richardson, E., Erlander, M., Sgroi, D. C. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res 11, R7 (2009).